Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) and Pro-Dex (NASDAQ:PDEX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.
Valuation & Earnings
This table compares Health Sciences Acquisitions Co. 2 and Pro-Dex’s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Health Sciences Acquisitions Co. 2 | N/A | N/A | -$380,000.00 | N/A | N/A |
| Pro-Dex | $42.04 million | 1.52 | $3.86 million | $1.27 | 14.17 |
Pro-Dex has higher revenue and earnings than Health Sciences Acquisitions Co. 2.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health Sciences Acquisitions Co. 2 | 0 | 0 | 0 | 0 | N/A |
| Pro-Dex | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares Health Sciences Acquisitions Co. 2 and Pro-Dex’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health Sciences Acquisitions Co. 2 | N/A | N/A | -2.38% |
| Pro-Dex | 9.72% | 19.00% | 9.85% |
Insider and Institutional Ownership
89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 14.6% of Pro-Dex shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 42.6% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk and Volatility
Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
Summary
Pro-Dex beats Health Sciences Acquisitions Co. 2 on 7 of the 8 factors compared between the two stocks.
About Health Sciences Acquisitions Co. 2
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
About Pro-Dex
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
